The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Thu, 28th May 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES BURBERRY PRICE TARGET TO 983 (959) PENCE - 'SELL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1380 (1225) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN TARGET TO 2440 (2400) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS BRITISH LAND CO PRICE TARGET TO 475 (550) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES M&G PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 1520 (1470) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES CRODA INTERNATIONAL TARGET TO 4100 (3900) PENCE - 'UNDERPERFORM'

----------

FTSE 250

----------

JEFFERIES INITIATES GREGGS WITH 'BUY' - TARGET 2375 PENCE

----------

JEFFERIES INITIATES GAMES WORKSHOP GROUP WITH 'BUY' - TARGET 8500 PENCE

----------

JEFFERIES RAISES BRITVIC PRICE TARGET TO 850 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 500 (575) PENCE - 'BUY'

----------

LIBERUM RAISES PAYPOINT PRICE TARGET TO 1000 (800) PENCE - 'BUY'

----------

DAVY RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERPERFORM')

----------

BARCLAYS CUTS TATE & LYLE PRICE TARGET TO 730 (800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PROVIDENT FINANCIAL TARGET TO 405 (510) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES HAYS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 120 (105) P

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 195 (210) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS DAILY MAIL PRICE TARGET TO 800 (950) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 708 (757) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLINIGEN PRICE TARGET TO 1050 (850) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Sep 2021 09:53

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Read more
9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 14:28

Clinigen signs UK distribution deal for Paion hospital drugs

Clinigen signs UK distribution deal for Paion hospital drugs

Read more
1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

Read more
1 Sep 2021 09:12

Allen out, Schnee in as Cliningen board chairman

(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.

Read more
25 Aug 2021 20:39

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

Read more
25 Aug 2021 07:34

Clinigen CFO Nick Keher steps down

(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".

Read more
5 Aug 2021 10:45

Clinigen inks partnership agreement with Eyevance Pharmaceuticals

(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.

Read more
5 Aug 2021 10:42

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Read more
3 Aug 2021 15:29

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

Read more
21 Jul 2021 14:44

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

Read more
14 Jul 2021 13:23

Wednesday broker round-up

(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.

Read more
13 Jul 2021 10:43

Clinigen expects annual revenue rise in transitional year

Clinigen expects annual revenue rise in transitional year

Read more
13 Jul 2021 09:36

Clinigen ends year in line with expectations

(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.

Read more
11 Jul 2021 18:55

Sunday share tips: Clinigen, UK companies

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.